The History and Development of HER2 Inhibitors

por Xia, Xiaohui, Gong, Chen, Zhang, Yinan, Xiong, Huihua
Publicado 2023

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma

por Li, Rui, Zhao, Weiheng, Liang, Rui, Jin, Chen, Xiong, Huihua
Publicado 2022

Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung Adenocarcinoma

por Mao, Shuangshuang, Chen, Zuhua, Wu, Yingying, Xiong, Huihua, Yuan, Xianglin
Publicado 2022

Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma

por Li, Rui, Jin, Chen, Zhao, Weiheng, Liang, Rui, Xiong, Huihua
Publicado 2022

Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges

por Liu, Junxia, Chao, Tengfei, Liu, Yingying, Gong, Chen, Zhang, Yinan, Xiong, Huihua
Publicado 2023

Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies

por Yang, Lin, Wei, Sheng, Zhao, Rongxian, Wu, Yingxing, Qiu, Hong, Xiong, Huihua
Publicado 2016

Psychometric properties of the Chinese version of adjustment disorder new module-20 in breast cancer patients

por Tang, Haiyan, Xiong, Huihua, Deng, Lingchao, Maercker, Andreas, Zhang, Jun, Meng, Heng
Publicado 2020

The landscape of chimeric antigen receptor T cell therapy in breast cancer: Perspectives and outlook

por Zhang, Hao, Zhu, Shuangli, Deng, Wanjun, Li, Rui, Zhou, Haiting, Xiong, Huihua
Publicado 2022

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer

por Zhang, Hao, Zhu, Shuangli, Zhou, Haiting, Li, Rui, Xia, Xiaohui, Xiong, Huihua
Publicado 2023

Comprehensive analysis of prognostic value, immune implication and biological function of CPNE1 in clear cell renal cell carcinoma

por Zhou, Haiting, He, Yi, Huang, Yongbiao, Li, Rui, Zhang, Hao, Xia, Xiaohui, Xiong, Huihua
Publicado 2023

Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy

por Zhang, Jing, Bai, Jian, Gong, Chen, Wang, Jianhua, Cheng, Yi, Zhao, Jing, Xiong, Huihua
Publicado 2023

Genetic variants in the plasminogen activator inhibitor‐1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients

por Liu, Bo, Tang, Yang, Yi, Minxiao, Liu, Qingxu, Xiong, Huihua, Hu, Guangyuan, Yuan, Xianglin
Publicado 2017

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma

por Su, Jinfang, Huang, Yongbiao, Wang, Yali, Li, Rui, Deng, Wanjun, Zhang, Hao, Xiong, Huihua
Publicado 2022

MET alterations in advanced pulmonary sarcomatoid carcinoma

por Gong, Chen, Xiong, Huihua, Qin, Kai, Wang, Jianhua, Cheng, Yi, Zhao, Jing, Zhang, Jing
Publicado 2022

Tantalum-carbon-integrated nanozymes as a nano-radiosensitizer for radiotherapy enhancement

por Li, Rui, Zhao, Weiheng, Wu, Tingting, Wang, Aifeng, Li, Qing, Liu, Ying, Xiong, Huihua
Publicado 2022

Effect of Ku80 on the radiosensitization of cisplatin in the cervical carcinoma cell line HeLa

por Zhuang, Liang, Liu, Fei, Peng, Ping, Xiong, Huihua, Qiu, Hong, Fu, Xiugen, Xiao, Zhiping, Huang, Xiaoyuan
Publicado 2018

Cytokeratin 18 regulates the transcription and alternative splicing of apoptotic-related genes and pathways in HeLa cells

por Cheng, Yi, Qin, Kai, Huang, Nan, Zhou, Zhipeng, Xiong, Huihua, Zhao, Jing, Zhang, Yi, Yu, Shiying
Publicado 2019

Celecoxib reverses the glioblastoma chemo-resistance to temozolomide through mitochondrial metabolism

por Yin, Delong, Jin, Guoqing, He, Hong, Zhou, Wei, Fan, Zhenbo, Gong, Chen, Zhao, Jing, Xiong, Huihua
Publicado 2021

FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1

por Huang, Tingting, Wang, Lei, Liu, Dian, Li, Piao, Xiong, Huihua, Zhuang, Liang, Sun, Li, Yuan, Xianglin, Qiu, Hong
Publicado 2017

Association of 15-hydroxyprostaglandin dehydrogenate and poor prognosis of obese breast cancer patients

por Wu, Ruxing, Liu, Tao, Yang, Peiwen, Liu, Xiyou, Liu, Fei, Wang, Ya, Xiong, Huihua, Yu, Shiying, Huang, Xiaoyuan, Zhuang, Liang
Publicado 2017